Wayfinder Medical
Wayfinder Medical
Navigate what comes next
CONDITION GUIDE

Arteriovenous Malformation (Brain)

Arteriovenous Malformation (Brain)

Medical Overview

A brain arteriovenous malformation (AVM) is an abnormal tangle of blood vessels where arteries connect directly to veins without the normal capillary network in between. Capillaries are the tiny vessels that slow blood flow and allow oxygen to pass from blood into brain tissue. Without them, high-pressure arterial blood flows straight into veins that are not built to handle that pressure.

This creates three problems. First, the abnormal vessels can rupture and bleed into the brain (hemorrhage). Second, the surrounding brain tissue does not get the oxygen it needs because blood is bypassing the capillaries. Third, the tangle of vessels can grow and press on nearby brain structures.

Most brain AVMs are believed to be congenital -- present from birth and formed during fetal development when the vascular system is assembling itself. The exact cause is not known. Genetic mutations affecting pathways that control blood vessel formation (including TGF-beta, VEGF, and Notch signaling) have been identified in some cases. AVMs are a hallmark feature of hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome.

Brain AVMs are rare, affecting roughly 1 in 100,000 people. An estimated 300,000 Americans have brain or spinal cord AVMs, but only about 12% develop symptoms. AVMs are most commonly discovered between ages 20 and 40, and the risk of symptoms peaks between 30 and 50. They affect men and women at roughly equal rates.

The annual risk of hemorrhage from a brain AVM is approximately 2-4%. About half of all people with brain AVMs first learn they have one when it bleeds. A hemorrhage from a brain AVM accounts for about 2% of all hemorrhagic strokes each year and is a leading cause of brain hemorrhage in children and young adults.

Diagnosis & Treatment

Getting Diagnosed

Many brain AVMs produce no symptoms and are only discovered incidentally during imaging for another problem -- a head injury, headaches, or a routine scan. When symptoms do appear, they may include seizures, headaches, muscle weakness or numbness, vision problems, difficulty speaking, or confusion.

Imaging is essential for diagnosis: Brain AVMs are graded using the Spetzler-Martin system, which assigns points based on size, location (whether near critical brain areas), and pattern of venous drainage. The grade (I through V) helps predict surgical risk.

Treatment

Treatment depends on the AVM's size, location, whether it has bled, and your overall health. The goal is to eliminate the AVM or reduce the risk of bleeding.

Surgical removal is the most definitive treatment. The surgeon opens the skull, seals the feeding arteries and draining veins, and removes the tangle. If the entire AVM is removed, it is considered cured. Surgery works best for smaller, accessible AVMs (lower Spetzler-Martin grades). Embolization involves threading a catheter to the AVM and injecting a glue-like substance or coils to block blood flow through it. This is often used before surgery to reduce the AVM's blood flow and make removal safer. In some cases, embolization alone can treat the AVM. Radiosurgery (Gamma Knife or CyberKnife) uses focused beams of radiation to slowly scar and close the AVM over 2-3 years. It works best for smaller AVMs and is used when surgery carries too much risk. Observation may be recommended if the AVM is in a location where treatment risks outweigh the annual hemorrhage risk. Regular imaging monitors for changes. Medications can manage symptoms but do not treat the AVM itself -- anti-seizure drugs, blood pressure medications, and pain relievers.

Recurrence after complete surgical removal is rare (less than 2%) but possible, particularly in children and young adults.

Accommodation Strategies

The functional impact of a brain AVM depends entirely on its location, whether it has bled, and what treatment you have had. Impacts can range from none (for unruptured, asymptomatic AVMs) to significant neurological deficits after a hemorrhage.

Common functional limitations after AVM hemorrhage or treatment: Workplace accommodations: Under the ADA, you do not need to disclose your specific diagnosis. Document the functional limitation and propose a reasonable accommodation.

Benefits & Disability

A brain AVM can qualify you for disability benefits, especially if it has caused a hemorrhage resulting in lasting neurological deficits.

Social Security Disability (SSDI/SSI)

The SSA evaluates brain AVM consequences under neurological listings:

The SSA requires documented neurological examination findings, imaging results, treatment records, and evidence that limitations have lasted or are expected to last at least 12 months. Key documentation strategy: If you have had a hemorrhage, document all neurological deficits with specific exam findings. If seizures are a factor, track their frequency, duration, and impact on function. Record cognitive testing results if memory, concentration, or executive function are impaired.

If you do not meet a specific listing, an RFC assessment can show you cannot sustain full-time work due to the combined effects of your limitations.

Workers' Compensation

AVMs are congenital, so workers' comp claims for the AVM itself are unlikely. However, if a workplace event triggered a hemorrhage or worsened symptoms, compensation for the resulting disability may be possible.

Notable Public Figures

Brain AVMs have affected several well-known people across different fields.

Pegi Young, musician and then-wife of Neil Young, had a craniotomy to remove a brain AVM more than 30 years before her death in 2019 and was open about her experience. Several athletes and public figures have also disclosed AVM diagnoses or survived AVM hemorrhages.

The AVM Survivors community has compiled accounts of public figures who have lived with or been treated for AVMs, though the condition remains far less recognized than other cerebrovascular conditions like stroke or aneurysm.

The relative rarity of brain AVMs means public awareness is low. Most advocacy and awareness efforts come from patient communities and organizations rather than celebrity attention.

Newly Diagnosed

If you just found out you have a brain AVM, here is what you need to know.

Not all AVMs need immediate treatment. Many brain AVMs are discovered incidentally and have never bled. Your medical team will evaluate the risk of hemorrhage against the risks of treatment based on your AVM's size, location, and characteristics. Observation with regular imaging is a legitimate option for some AVMs. The annual risk of bleeding is real but not enormous. The 2-4% per year hemorrhage rate is cumulative over a lifetime, which is why treatment is often recommended for younger patients. This is a conversation to have with a neurosurgeon who has specific experience with AVMs. Find a neurosurgeon and center with AVM expertise. AVMs are rare, and treatment outcomes depend heavily on the skill and experience of the team. Major neurosurgery centers with cerebrovascular programs are where you want to be evaluated. Seizures may be the first symptom you notice. If you have had a seizure, get medical evaluation immediately. Seizure management is straightforward in most cases and does not necessarily mean the AVM is bleeding. If your AVM has bled, the immediate focus is stabilization and recovery. The neurological deficits from a hemorrhage may improve over time with rehabilitation. Recovery is not instant -- it can take months. Living with an untreated AVM means living with uncertainty. That psychological weight is real. Anxiety about hemorrhage, seizures, or sudden disability is common and valid. Therapy or counseling is not a sign of weakness -- it is a practical tool for managing a situation that involves genuine risk. Connect with others. The AVM Survivors Network (avmsurvivors.org) is a Ben's Friends community for patients and families. The Aneurysm and AVM Foundation (TAAF, taafonline.org) provides support groups, education, and research funding.

Culture & Media

Brain AVMs have minimal representation in mainstream media. The condition occasionally appears in medical dramas as a plot device -- a sudden brain bleed requiring emergency surgery -- but sustained, accurate portrayal is essentially nonexistent.

The real conversation about AVMs happens in patient communities. The AVM Survivors Network and the TAAF support groups are where people share their experiences with diagnosis, treatment decisions, recovery from hemorrhage, and the ongoing psychological impact of living with a known vascular malformation in their brain.

One recurring theme in patient narratives is the tension between the medical concept of "watchful waiting" and the lived experience of knowing something in your brain could bleed at any time. Another is the difficulty of explaining the condition to employers, friends, or family -- especially when the AVM has not bled and you appear completely healthy.

Creators & Resources

Organizations

Support Communities

Medical Resources

Key Statistics